Clinical classification of dopaminergic effects in parkinsonism
- 31 March 1992
- journal article
- review article
- Published by Elsevier in Neurochemistry International
- Vol. 20, 335-337
- https://doi.org/10.1016/0197-0186(92)90261-o
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Central Mechanisms and Levodopa Response Fluctuations in Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- LISURIDE INFUSION PUMP: A DEVICE FOR THE TREATMENT OF MOTOR FLUCTUATIONS IN PARKINSON'S DISEASEThe Lancet, 1986
- The role of D-1 and D-2 receptorsNature, 1980
- Multiple receptors for dopamineNature, 1979
- Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphineEuropean Journal of Pharmacology, 1978
- Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical dataPsychopharmacology, 1976
- Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activityPsychopharmacology, 1973
- Stereotaxic Mapping of the Monoamine Pathways in the Rat Brain*Acta Physiologica Scandinavica, 1971